Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases. Its pipeline includes CLS-AX, an Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
32
Frequently Asked Questions
What is Market Cap of Clearside Biomedical Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Clearside Biomedical Inc market cap is $27.45M.
What is the 52-week high for Clearside Biomedical Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Clearside Biomedical Inc 52 week high is $1.65 as of September 12, 2025.
What is the 52-week low for Clearside Biomedical Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Clearside Biomedical Inc 52 week low is $0.292 as of September 12, 2025.
What is Clearside Biomedical Inc stock price today?
Clearside Biomedical Inc stock price today is $0.3238.
What was Clearside Biomedical Inc stock price yesterday?
Clearside Biomedical Inc stock price yesterday was $0.3496.
What is the PE ratio of Clearside Biomedical Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Clearside Biomedical Inc’s P/E ratio is -0.96.
What is the Price-to-Book ratio of Clearside Biomedical Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Clearside Biomedical Inc P/B ratio is -0.5631.
What is the 50-day moving average of Clearside Biomedical Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Clearside Biomedical Inc 50-day moving average is $0.4963.
How many employess does Clearside Biomedical Inc has?
